Thierry Buclin


Ontology type: schema:Person     


Person Info

NAME

Thierry

SURNAME

Buclin

Publications in SciGraph latest 50 shown

  • 2021-05-18 Pharmacokinetics of anti-infective agents during CytoSorb hemoadsorption in SCIENTIFIC REPORTS
  • 2021-01-16 Population pharmacokinetic modelling to quantify the magnitude of drug-drug interactions between amlodipine and antiretroviral drugs in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2020-10-29 Pharmacokinetic/Pharmacodynamic Modelling to Describe the Cholesterol Lowering Effect of Rosuvastatin in People Living with HIV in CLINICAL PHARMACOKINETICS
  • 2020-04-12 Influence of Drug–Drug Interactions on the Pharmacokinetics of Atorvastatin and Its Major Active Metabolite ortho-OH-Atorvastatin in Aging People Living with HIV in CLINICAL PHARMACOKINETICS
  • 2019-06-12 Methods for Personalised Delivery Rate Computation for IV Administered Anesthetic Propofol in AUTOMATED REASONING FOR SYSTEMS BIOLOGY AND MEDICINE
  • 2019-03-25 Complementary medicine use during cancer treatment and potential herb-drug interactions from a cross-sectional study in an academic centre in SCIENTIFIC REPORTS
  • 2018-02-27 Antiepileptika in der Stillzeit in DER NERVENARZT
  • 2017-02-16 Renal Drug Transporters and Drug Interactions in CLINICAL PHARMACOKINETICS
  • 2016-12-17 Pharmacokinetics of lenalidomide during high cut-off dialysis in a patient with multiple myeloma and renal failure in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2016-07-16 Biases affecting injected doses of an experimental drug during clinical trials in TRIALS
  • 2014-10-09 Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trial in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2014-05-28 Antiepileptika bei Frauen im gebärfähigen Alter und in der Schwangerschaft in DER NERVENARZT
  • 2014-03-04 Tobramycin exposure from active calcium sulfate bone graft substitute in BMC PHARMACOLOGY AND TOXICOLOGY
  • 2013-07-10 Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients in MALARIA JOURNAL
  • 2012-12-28 Imatinib-induced dose-dependent interstitial lung disease successfully switched to nilotinib: a case report with concentration exposure data in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2012-11-30 Benchmarking Therapeutic Drug Monitoring Software: A Review of Available Computer Tools in CLINICAL PHARMACOKINETICS
  • 2012-06-07 Therapeutic Drug Monitoring of Targeted Anticancer Therapy. Tyrosine Kinase Inhibitors and Selective Estrogen Receptor Modulators: A Clinical Pharmacology Laboratory Perspective in LC-MS IN DRUG BIOANALYSIS
  • 2012-03 Therapeutic Drug Monitoring of Imatinib in CLINICAL PHARMACOKINETICS
  • 2010-11 Oseltamivir in Seasonal, Avian H5N1 and Pandemic 2009 A/H1N1 Influenza in CLINICAL PHARMACOKINETICS
  • 2010-10-12 Systemic exposure to tobramycin after local antibiotic treatment with calcium sulphate as carrier material in ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY
  • 2010-02-23 Imatinib plasma levels: correlation with clinical benefit in GIST patients in BRITISH JOURNAL OF CANCER
  • 2010-01-06 Variable viral clearance despite adequate ganciclovir plasma levels during valganciclovir treatment for cytomegalovirus disease in D+/R- transplant recipients in BMC INFECTIOUS DISEASES
  • 2009-06 Valganciclovir in Adult Solid Organ Transplant Recipients in CLINICAL PHARMACOKINETICS
  • 2009-02-03 The bioavailability of bromazepam, omeprazole and paracetamol given by nasogastric feeding tube in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2009-01 "Iatrogenicity cascade": Doing harm by treating harm? in WIENER MEDIZINISCHE WOCHENSCHRIFT
  • 2008-12 Antidepressants for the Treatment of Chronic Pain in DRUGS
  • 2008-06-28 A phase I pharmacokinetic study of hypoxic abdominal stop-flow perfusion with gemcitabine in patients with advanced pancreatic cancer and refractory malignant ascites in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2008-05-06 Relationship of imatinib-free plasma levels and target genotype with efficacy and tolerability in BRITISH JOURNAL OF CANCER
  • 2007-11-14 Glutathione Precursor, N-Acetyl-Cysteine, Improves Mismatch Negativity in Schizophrenia Patients in NEUROPSYCHOPHARMACOLOGY
  • 2007-04-12 Reply to Zong et al. in LEUKEMIA
  • 2007-04-12 Resistance reversal by RNAi silencing of MDR1 in CML cells associated with increase in imatinib intracellular levels in LEUKEMIA
  • 2006-10-22 Orosomucoid (α1‐acid glycoprotein) plasma concentration and genetic variants: Effects on human immunodeficiency virus protease inhibitor clearance and cellular accumulation in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2005-04-02 The Importance of Assessing the Dose Actually Administered in Pharmacokinetic Trials in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2005-04-01 Two cases of "cannabis acute psychosis" following the administration of oral cannabis in BMC PSYCHIATRY
  • 2005-02-05 Effect of dronedarone on renal function in healthy subjects in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2005-01-19 Variations of CYP3A activity induced by antiretroviral treatment in HIV-1 infected patients in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2004-04-28 Pharmacokinetics of midazolam in CYP3A4- and CYP3A5-genotyped subjects in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2004-04-28 Oral administration of a low dose of midazolam (75 μg) as an in vivo probe for CYP3A activity in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2004-02-26 Pharmacokinetic and pharmacodynamic profile of icatibant in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2004-02-26 Icatibant has no impact on renal function in healthy subjects in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2004-02-26 The bradykinin antagonist icatibant increases electrolyte and water excretion after sodium challenge in patients with liver cirrhosis in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2004-01-22 Polymorphisms in Human MDR1 (P‐glycoprotein): Recent Advances and Clinical Relevance in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2003-02-16 Population pharmacokinetics and effects of indinavir in HIV infected patients in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2003-01-02 Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2002-12 Interindividual Variability of the Clinical Pharmacokinetics of Methadone in CLINICAL PHARMACOKINETICS
  • 2002-02 Population Pharmacokinetic-Pharmacodynamic Modelling of Angiotensin Receptor Blockade in Healthy Volunteers in CLINICAL PHARMACOKINETICS
  • 2001-10-30 Population pharmacokinetics of fluconazole given for secondary prevention of oropharyngeal candidiasis in HIV-positive patients in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2001-06 Diet Acids and Alkalis Influence Calcium Retention in Bone in OSTEOPOROSIS INTERNATIONAL
  • 2001-06 Psychopharmacology in supportive care of cancer: a review for the clinician in SUPPORTIVE CARE IN CANCER
  • 2000-10 Type 1 IFNs in human versus mouse in NATURE IMMUNOLOGY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.9851.5", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7700.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.150338.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.8515.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417993.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.497605.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417924.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.31564.35", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.152326.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5734.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411795.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411656.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412004.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.4991.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414250.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.483026.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.482954.6", 
            "type": "Organization"
          }
        ], 
        "familyName": "Buclin", 
        "givenName": "Thierry", 
        "id": "sg:person.01230116133.26", 
        "identifier": [
          {
            "name": "orcid_id", 
            "type": "PropertyValue", 
            "value": "0000-0003-0639-5536"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01230116133.26", 
          "https://orcid.org/0000-0003-0639-5536"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-12-01T07:13", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/person/person_810.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01230116133.26'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01230116133.26'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01230116133.26'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01230116133.26'


     

    This table displays all metadata directly associated to this object as RDF triples.

    53 TRIPLES      11 PREDICATES      29 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.01230116133.26 schema:affiliation Nd15de6bbed52485f8672e9728be53fa3
    2 grid-institutes:grid.150338.c
    3 grid-institutes:grid.152326.1
    4 grid-institutes:grid.31564.35
    5 grid-institutes:grid.411656.1
    6 grid-institutes:grid.411795.f
    7 grid-institutes:grid.412004.3
    8 grid-institutes:grid.414250.6
    9 grid-institutes:grid.417924.d
    10 grid-institutes:grid.417993.1
    11 grid-institutes:grid.482954.6
    12 grid-institutes:grid.483026.b
    13 grid-institutes:grid.497605.9
    14 grid-institutes:grid.4991.5
    15 grid-institutes:grid.5734.5
    16 grid-institutes:grid.7700.0
    17 grid-institutes:grid.8515.9
    18 schema:familyName Buclin
    19 schema:givenName Thierry
    20 schema:identifier N4cc4a6d4aeed4a40bc8d019f71d61a4b
    21 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01230116133.26
    22 https://orcid.org/0000-0003-0639-5536
    23 schema:sdDatePublished 2022-12-01T07:13
    24 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    25 schema:sdPublisher N80c256220aad4cdb80fe2a4dab327ba8
    26 sgo:license sg:explorer/license/
    27 sgo:sdDataset persons
    28 rdf:type schema:Person
    29 N4cc4a6d4aeed4a40bc8d019f71d61a4b schema:name orcid_id
    30 schema:value 0000-0003-0639-5536
    31 rdf:type schema:PropertyValue
    32 N80c256220aad4cdb80fe2a4dab327ba8 schema:name Springer Nature - SN SciGraph project
    33 rdf:type schema:Organization
    34 Nd15de6bbed52485f8672e9728be53fa3 schema:affiliation grid-institutes:grid.9851.5
    35 sgo:isCurrent true
    36 rdf:type schema:OrganizationRole
    37 grid-institutes:grid.150338.c schema:Organization
    38 grid-institutes:grid.152326.1 schema:Organization
    39 grid-institutes:grid.31564.35 schema:Organization
    40 grid-institutes:grid.411656.1 schema:Organization
    41 grid-institutes:grid.411795.f schema:Organization
    42 grid-institutes:grid.412004.3 schema:Organization
    43 grid-institutes:grid.414250.6 schema:Organization
    44 grid-institutes:grid.417924.d schema:Organization
    45 grid-institutes:grid.417993.1 schema:Organization
    46 grid-institutes:grid.482954.6 schema:Organization
    47 grid-institutes:grid.483026.b schema:Organization
    48 grid-institutes:grid.497605.9 schema:Organization
    49 grid-institutes:grid.4991.5 schema:Organization
    50 grid-institutes:grid.5734.5 schema:Organization
    51 grid-institutes:grid.7700.0 schema:Organization
    52 grid-institutes:grid.8515.9 schema:Organization
    53 grid-institutes:grid.9851.5 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...